- Mithra Pharmaceuticals announced today the appointment of Marc Coucke as chairman of the Board of Directors.
- Other changes also occured in the Board of Directors of Mithra Pharmaceuticals.
- Koen Hoffman, CEO of Value Square and former CEO of KBC Securities, was appointed independent director and will become chairman of the audit committee of Mithra.
- Freya Loncin, General Counsel Alychlo, was appointed new non-executive director.
- Professor Jean-Michel Foidart, co-founder of Mithra and current co-chairman of the Scientific Committee of Mithra Pharmaceuticals, was appointed non-executive director.
Liège, Belgium, 26 August 2016 – During the last board meeting, the Board of Directors of Mithra unanimously appointed Marc Coucke as Chairman.